metronidazole has been researched along with albendazole in 68 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 18 (26.47) | 18.2507 |
2000's | 22 (32.35) | 29.6817 |
2010's | 22 (32.35) | 24.3611 |
2020's | 6 (8.82) | 2.80 |
Authors | Studies |
---|---|
Castillo, R; Cedillo, R; Cortés, R; Hernädez-Luis, F; Hernández, M; Hernández-Campos, A; Morales, R; Navarrete-Vázquez, G; Valdez, J; Yépez, L | 1 |
Castillo, R; Cedillo, R; Cortés, R; Hernández, M; Hernández-Campos, A; Hernández-Luis, F; Navarrete-Vázquez, G; Tapia, A; Valdez, J; Yépez, L | 1 |
Castillo, R; Hernández-Campos, A; Hernández-Luis, F; Rodríguez-Morales, S; Tapia-Contreras, A; Valdez-Padilla, D; Yépez-Mulia, L | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Castillo, R; Hernández-Campos, A; Hernández-Hernández, M; Hernández-Luis, F; Navarrete-Vázquez, G; Soria-Arteche, O; Yépez-Mulia, L | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Castillo, R; Hernández-Campos, A; Hernández-Luis, F; Pérez-Villanueva, J; Romo-Mancillas, A; Yépez-Mulia, L | 1 |
Castillo, R; Hernández-Campos, A; Hernández-Covarrubias, C; Hernández-Luis, F; Navarrete-Vázquez, G; Sánchez-Díaz, R; Vilchis-Reyes, MA; Yépez-Mulia, L | 1 |
Castillo, R; Hernández-Campos, A; Hernández-Luis, F; Méndez-Cuesta, C; Méndez-Lucio, O; Pérez-Villanueva, J; Yépez-Mulia, L | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Bathurst, I; Burrows, JN; Charman, SA; Cross, RM; Flanigan, DL; Fronczek, FR; Guida, WC; Kyle, DE; LaCrue, AN; Maignan, JR; Manetsch, R; Monastyrskyi, A; Mutka, TS; Sáenz, FE; Shackleford, DM; White, KL; Wojtas, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Aguayo-Ortiz, R; Castillo, R; Flores-Carrillo, P; Hernández-Campos, A; Trejo-Soto, PJ; Velázquez-López, JM; Yépez-Mulia, L | 1 |
Hart, CJS; Riches, A; Skinner-Adams, TS; Trenholme, KR | 1 |
Cortés-Benítez, F; Palacios-Espinosa, JF; Pérez-Villanueva, J; Rodríguez-Villar, K; Soria-Arteche, O; Yépez-Mulia, L | 1 |
Chakraborty, PR; Edlind, TD; Hang, TL | 1 |
Farbey, MD; Reynoldson, JA; Thompson, RC | 1 |
Asmuth, DM; DeGirolami, PC; Desai, G; Ezratty, CR; Federman, M; Pleskow, DK; Wanke, CA | 1 |
Oxberry, ME; Reynoldson, JA; Thompson, RC | 1 |
Kvalsvig, JD; Pillai, G; Taylor, M | 1 |
Agarwal, V; Jagota, SC; Kumar, A; Misra, PK | 2 |
Bonaccorso, V; Bonforte, S; Brancati, G; Cacopardo, B; Di Paola, O; Patamia, I | 1 |
Pearce, DA; Reynoldson, JA; Thompson, RC | 1 |
Brasseur, P; Favennec, L | 1 |
Leitch, GJ; Scanlon, M; Shaw, A; Visvesvara, GS; Wallace, S | 1 |
Furnée, CA; Hautvast, JG; van der Haar, F; West, CE | 1 |
Meyer, EK | 1 |
Crowe, SM; Leder, K; Ryan, N; Spelman, D | 1 |
Cummings, TS; Doerr, J; Hegngi, FN; Larsen, CT; Pierson, FW; Saunders, G; Schwartz, RD; Zajac, A | 1 |
Haroon, TS; Mahboob, A | 1 |
Sangmaneedet, S; Smith, SA | 1 |
Dini, LA; Frean, JA; Grimwood, AJ; von Gottberg, AM | 1 |
Ballet, JJ; Brasseur, P; Favennec, L; Lemée, V; Nevez, G; Rabodonirina, M; Zaharia, I | 1 |
Upcroft, JA; Upcroft, P | 1 |
Abboud, P; Ballet, JJ; Borsa-Lebas, F; Brasseur, P; Caron, F; Favennec, L; Gargala, G; Lemée, V | 1 |
Azeredo, Z; Cabral, M; Cruz, A; Figueiredo de Sousa, JC; Leite, E; Sousa, MI | 1 |
Azeredo, Z; Cabral, M; Carolina Silva, M; Cruz, A; Figueiredo de Sousa, JC; Isaura Sousa, M; Manso, O | 1 |
Castillo, R; Cedillo, R; González, J; Hernández-Campos, A; Hernández-Luis, F; Martínez-Fernández, A; Martínez-Grueiro, M; Navarrete-Vázquez, G; Tapia, A; Yépez, L | 1 |
Arinc, H; Celebi, H; Gunduz, H; Karabay, O; Kayas, D; Tamer, A | 1 |
Balcioğlu, IC; Ertan, P; Limoncu, E; Onağ, A; Yereli, K | 1 |
Ganguly, NK; Mahajan, RC; Sandhu, H | 1 |
Castillo, R; Gerena, L; Hernández-Campos, A; Hernández-Luis, F; Meléndez, V; Navarrete-Vázquez, G; Rojano-Vilchis, Mde M; Yépez-Mulia, L | 1 |
Alizadeh, A; Bodaghi, M; Kashani, KM; Ranjbar, M; Taheri, MM | 1 |
Banda, B; Cohen, MS; Gama, S; Hoffman, I; Hosseinipour, MC; Joaki, G; Martinson, F; Mbeye, N; Napravnik, S | 1 |
Hess, C; Peter, S; Sawatzki, M | 1 |
Hanevik, K; Langeland, N; Mørch, K; Robertson, LJ; Strand, EA | 1 |
Brown, C; Kiser, JD; Paulson, CP | 1 |
Eide, GE; Hanevik, K; Hausken, T; Langeland, N; Mørch, K | 1 |
Goto, R; Lunn, PG; Mascie-Taylor, CG | 1 |
Genkinger, JM; Loffredo, CA; Singer, SM; Solaymani-Mohammadi, S | 1 |
Brito, K; Cañete, R; Guilhem, D; Mesa, L; Novaes, MR; Prior, A; Rodríguez, P | 1 |
Criollo, CP; Granados, CE; Reveiz, L; Uribe, LG | 1 |
da Costa, LF; de Castro, JM; Lallo, MA | 1 |
Bhuiyan, TR; Choudhury, FK; Khanam, F; Lundgren, A; Qadri, F; Sack, DA; Saha, A; Salma, U; Sayeed, MA; Svennerholm, AM | 1 |
Castillo-Villanueva, A; de la Mora-de la Mora, I; Enríquez-Flores, S; Figueroa-Salazar, R; García-Torres, I; Gómez-Manzo, S; Gutiérrez-Castrellón, P; Hernández-Alcántara, G; López-Velázquez, G; Marcial-Quino, J; Méndez, ST; Oria-Hernández, J; Reyes-Vivas, H; Torres-Arroyo, A; Vanoye-Carlo, A; Yépez-Mulia, L | 1 |
Carter, ER; Chiodini, PL; Hedley, L; Nabarro, LE | 1 |
Leitsch, D | 1 |
Fanshawe, TR; McCarthy, ND; Ordóñez-Mena, JM | 1 |
Almirall, P; Avila, I; Chirino, E; Duque, A; Escobedo, AA; Pacheco, F | 1 |
Iza, JA; Iza, SN; Olivera, MJ | 1 |
Hanevik, K; Mørch, K | 1 |
Ali, OT; Almalki, AJ; Hassan, WS; Khayyat, AN; Sebaiy, MM | 1 |
Bezagio, RC; Colli, CM; de Almeida, CR; Ferrari, A; Gomes, ML; Romera, LIL | 1 |
Argüello-García, R; González-Hernández, I; Jung-Cook, H; Ortega-Pierres, MG; Pech-Santiago, EO; Rafferty, SP; Saavedra, E; Vázquez, C | 1 |
10 review(s) available for metronidazole and albendazole
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Anti-
Topics: Animals; Antiprotozoal Agents; Benzimidazoles; Drug Delivery Systems; Drug Discovery; Drug Therapy, Combination; Gastrointestinal Tract; Giardia; Giardiasis; Humans; Nitroimidazoles | 2020 |
Clinical features of microsporidiosis in patients with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Boston; CD4-Positive T-Lymphocytes; Chronic Disease; Diarrhea; Humans; Intestinal Diseases, Parasitic; Leukocyte Count; Malabsorption Syndromes; Male; Metronidazole; Microsporida; Microsporidiosis; Retrospective Studies | 1994 |
Microsporidial disease in HIV-infected patients: a report of 42 patients and review of the literature.
Topics: Adult; Aged; Albendazole; Animals; Anti-Infective Agents; Antiprotozoal Agents; Apansporoblastina; Encephalitozoonosis; Feces; Female; HIV Infections; Humans; Male; Metronidazole; Microsporidiosis; Middle Aged; Retrospective Studies | 1998 |
Clinical inquiries. What's the most effective treatment for giardiasis?
Topics: Albendazole; Antinematodal Agents; Antitrichomonal Agents; Giardiasis; Humans; Mebendazole; Metronidazole; Tinidazole | 2008 |
A meta-analysis of the effectiveness of albendazole compared with metronidazole as treatments for infections with Giardia duodenalis.
Topics: Albendazole; Antiprotozoal Agents; Giardia lamblia; Giardiasis; Humans; Metronidazole; Randomized Controlled Trials as Topic; Treatment Outcome | 2010 |
Drugs for treating giardiasis.
Topics: Adult; Albendazole; Antiparasitic Agents; Child; Giardiasis; Humans; Mebendazole; Metronidazole; Nitro Compounds; Randomized Controlled Trials as Topic; Thiazoles; Tinidazole | 2012 |
Nitroimidazole-refractory giardiasis: a growing problem requiring rational solutions.
Topics: Albendazole; Antiprotozoal Agents; Chloroquine; Drug Resistance; Drug Therapy, Combination; Giardia lamblia; Giardiasis; Humans; Metronidazole; Quinacrine; Tinidazole; Treatment Failure | 2018 |
Comparative efficacy of drugs for treating giardiasis: a systematic update of the literature and network meta-analysis of randomized clinical trials.
Topics: Adult; Albendazole; Antiprotozoal Agents; Child; Giardiasis; Humans; Metronidazole; Network Meta-Analysis; Randomized Controlled Trials as Topic; Tinidazole; Treatment Outcome | 2018 |
Giardiasis treatment: an update with a focus on refractory disease.
Topics: Adult; Albendazole; Antiprotozoal Agents; Benzimidazoles; Child; Diarrhea; Drug Resistance; Drug Therapy, Combination; Female; Giardia; Giardiasis; Humans; Male; Mebendazole; Metronidazole; Nitroimidazoles; Quinacrine | 2020 |
11 trial(s) available for metronidazole and albendazole
Article | Year |
---|---|
A comparative clinical trial of albendazole versus metronidazole in giardiasis.
Topics: Albendazole; Anorexia; Antiprotozoal Agents; Child; Child, Preschool; Female; Giardiasis; Humans; Male; Metronidazole | 1995 |
A comparative clinical trial of albendazole versus metronidazole in children with giardiasis.
Topics: Albendazole; Anorexia; Antiprotozoal Agents; Child; Child, Preschool; Female; Giardiasis; Humans; Infant; Male; Metronidazole | 1995 |
[Synergic effect of albendazole plus metronidazole association in the treatment of metronidazole-resistant giardiasis].
Topics: Adult; Albendazole; Animals; Antiprotozoal Agents; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Female; Giardia lamblia; Giardiasis; Humans; Male; Metronidazole | 1995 |
Effect of intestinal parasite treatment on the efficacy of oral iodized oil for correcting iodine deficiency in schoolchildren.
Topics: Administration, Oral; Albendazole; Anthelmintics; Antitrichomonal Agents; Child; Feces; Humans; Intestinal Absorption; Intestinal Diseases, Parasitic; Iodine; Iodized Oil; Malawi; Metronidazole | 1997 |
Albendazole versus metronidazole treatment of adult giardiasis: An open randomized clinical study.
Topics: Adult; Albendazole; Antiprotozoal Agents; Antitrichomonal Agents; Female; Giardiasis; Humans; Male; Metronidazole; Middle Aged; Prospective Studies; Treatment Outcome | 2004 |
Albendazole as an alternative therapeutic agent for childhood giardiasis in Turkey.
Topics: Adolescent; Albendazole; Animals; Antiprotozoal Agents; Child; Child, Preschool; Female; Giardia lamblia; Giardiasis; Humans; Male; Metronidazole; Treatment Outcome; Turkey | 2004 |
Albendazole versus metronidazole in the treatment of patients with giardiasis in the Islamic Republic of Iran.
Topics: Adolescent; Adult; Albendazole; Anorexia; Antiprotozoal Agents; Child; Child, Preschool; Drug Administration Schedule; Feces; Female; Follow-Up Studies; Giardiasis; Humans; Iran; Male; Metronidazole; Middle Aged; Safety; Single-Blind Method; Taste Disorders; Treatment Outcome; Urban Health | 2006 |
Effects of albendazole/metronidazole or tetracycline/folate treatments on persisting symptoms after Giardia infection: a randomized open clinical trial.
Topics: Adult; Albendazole; Animals; Antiprotozoal Agents; Feces; Female; Folic Acid; Giardia; Giardiasis; Humans; Male; Metronidazole; Prospective Studies; Severity of Illness Index; Tetracycline; Treatment Outcome | 2008 |
Impact of anti-Giardia and anthelminthic treatment on infant growth and intestinal permeability in rural Bangladesh: a randomised double-blind controlled study.
Topics: Albendazole; Animals; Anthelmintics; Anthropometry; Antiprotozoal Agents; Bangladesh; Breast Feeding; Double-Blind Method; Female; Giardiasis; Growth; Growth Disorders; Humans; Infant; Intestinal Mucosa; Longitudinal Studies; Male; Metronidazole; Mothers | 2009 |
Albendazole versus metronidazole in the treatment of adult giardiasis: a randomized, double-blind, clinical trial.
Topics: Adult; Age of Onset; Albendazole; Antiprotozoal Agents; Cuba; Double-Blind Method; Drug Administration Schedule; Giardiasis; Humans; Metronidazole; Treatment Outcome | 2012 |
Evaluation of immune responses to an oral typhoid vaccine, Ty21a, in children from 2 to 5 years of age in Bangladesh.
Topics: Administration, Oral; Albendazole; Anthelmintics; Antibodies, Bacterial; Bangladesh; Child, Preschool; Double-Blind Method; Female; Humans; Male; Metronidazole; Pilot Projects; Polysaccharides, Bacterial; T-Lymphocytes; Typhoid Fever; Typhoid-Paratyphoid Vaccines | 2014 |
47 other study(ies) available for metronidazole and albendazole
Article | Year |
---|---|
Synthesis and antiparasitic activity of 2-(trifluoromethyl)-benzimidazole derivatives.
Topics: Animals; Antiparasitic Agents; Benzimidazoles; Brain Chemistry; Entamoeba histolytica; Fluorine Compounds; Giardia lamblia; Larva; Rats; Rats, Wistar; Trichinella spiralis; Tubulin | 2001 |
Synthesis and antiparasitic activity of 1H-benzimidazole derivatives.
Topics: Albendazole; Animals; Antiparasitic Agents; Benzimidazoles; Brain; Eukaryota; Metronidazole; Molecular Structure; Rats; Trichinella spiralis; Tubulin | 2002 |
Synthesis and antiprotozoal activity of novel 1-methylbenzimidazole derivatives.
Topics: Antiprotozoal Agents; Benzimidazoles; Microbial Sensitivity Tests; Parasitic Sensitivity Tests; Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Synthesis and biological activity of 2-(trifluoromethyl)-1H-benzimidazole derivatives against some protozoa and Trichinella spiralis.
Topics: Animals; Antiprotozoal Agents; Benzimidazoles; Inhibitory Concentration 50; Larva; Mice; Trichinella spiralis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Antiprotozoal activity of proton-pump inhibitors.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antiprotozoal Agents; Drug Design; Entamoeba histolytica; Giardia lamblia; Humans; Lansoprazole; Omeprazole; Pantoprazole; Parasitic Diseases; Proton Pump Inhibitors; Rabeprazole; Trichomonas vaginalis | 2011 |
Exploring the interplay of physicochemical properties, membrane permeability and giardicidal activity of some benzimidazole derivatives.
Topics: Antiprotozoal Agents; Benzimidazoles; Caco-2 Cells; Cell Membrane Permeability; Chemical Phenomena; Duodenum; Giardia lamblia; Humans; Hydrophobic and Hydrophilic Interactions; Jejunum; Solubility; Trophozoites; Water | 2012 |
Synthesis and antiprotozoal activity of novel 2-{[2-(1H-imidazol-1-yl)ethyl]sulfanyl}-1H-benzimidazole derivatives.
Topics: Antiprotozoal Agents; Benzimidazoles; Drug Design; Entamoeba histolytica; Giardia lamblia; Metronidazole; Phenylenediamines; Structure-Activity Relationship; Trichomonas vaginalis | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Orally bioavailable 6-chloro-7-methoxy-4(1H)-quinolones efficacious against multiple stages of Plasmodium.
Topics: Animals; Antimalarials; Humans; Inhibitory Concentration 50; Malaria; Mice; Microsomes, Liver; Parasitemia; Plasmodium; Plasmodium berghei; Quinolones; Structure-Activity Relationship | 2014 |
Synthesis, antiprotozoal activity, and chemoinformatic analysis of 2-(methylthio)-1H-benzimidazole-5-carboxamide derivatives: Identification of new selective giardicidal and trichomonicidal compounds.
Topics: Antiprotozoal Agents; Benzimidazoles; Dose-Response Relationship, Drug; Entamoeba histolytica; Giardia lamblia; Molecular Structure; Parasitic Sensitivity Tests; Structure-Activity Relationship; Trichomonas vaginalis | 2017 |
The giardicidal activity of lobendazole, fabomotizole, tenatoprazole and ipriflavone: A ligand-based virtual screening and in vitro study.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antiprotozoal Agents; Benzimidazoles; Carbamates; Humans; In Vitro Techniques; Isoflavones; Ligands | 2021 |
Residues of some veterinary drugs in animals and foods. Joint FAO/WHO Expert Committee on Food Additives.
Topics: Albendazole; Anabolic Agents; Animals; Antiprotozoal Agents; Dimetridazole; Diminazene; Drug Residues; Food Contamination; Humans; Ipronidazole; Metronidazole; Molecular Structure; Phenanthridines; Ronidazole; Sulfamethazine; Sulfathiazole; Sulfathiazoles; Trenbolone Acetate; Trypanocidal Agents | 1990 |
Activity of the anthelmintic benzimidazoles against Giardia lamblia in vitro.
Topics: Albendazole; Animals; Dose-Response Relationship, Drug; Drug Resistance; Giardia; Mebendazole; Metronidazole; Quinacrine; Thiabendazole | 1990 |
In vitro drug susceptibility of 29 isolates of Giardia duodenalis from humans as assessed by an adhesion assay.
Topics: Albendazole; Animals; Cell Adhesion; Dose-Response Relationship, Drug; Giardia; Giardiasis; Humans; Metronidazole; Native Hawaiian or Other Pacific Islander; Western Australia; White People | 1995 |
Evaluation of the effects of albendazole and metronidazole on the ultrastructure of Giardia duodenalis, Trichomonas vaginalis and Spironucleus muris using transmission electron microscopy.
Topics: Albendazole; Animals; Diplomonadida; Dose-Response Relationship, Drug; Giardia; Metronidazole; Microscopy, Electron; Trichomonas vaginalis | 1994 |
Targeted chemotherapy for parasite infestations in rural black preschool children.
Topics: Albendazole; Antiparasitic Agents; Black or African American; Black People; Cestode Infections; Child; Child, Preschool; Humans; Metronidazole; Nematode Infections; Parasitic Diseases; Praziquantel; Protozoan Infections; Rural Health; South Africa; Trematode Infections | 1995 |
A comparison of two methods for assessing drug sensitivity in Giardia duodenalis.
Topics: Albendazole; Animals; Antiprotozoal Agents; Giardia; Metronidazole | 1996 |
Two cases of giardiasis unsuccessfully treated by albendazole.
Topics: Adult; Albendazole; Animals; Antiprotozoal Agents; Giardia; Giardiasis; Humans; Male; Metronidazole | 1995 |
Use of a fluorescent probe to assess the activities of candidate agents against intracellular forms of Encephalitozoon microsporidia.
Topics: Albendazole; Animals; Antiprotozoal Agents; Cell Survival; Cells, Cultured; Chlorocebus aethiops; Cyclohexanes; Encephalitozoon; Fatty Acids, Unsaturated; Fluoresceins; Fluorescent Dyes; Itraconazole; Kidney; Metronidazole; Microscopy, Confocal; Sesquiterpenes | 1997 |
Adverse events associated with albendazole and other products used for treatment of giardiasis in dogs.
Topics: Adverse Drug Reaction Reporting Systems; Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Cat Diseases; Cats; Dog Diseases; Dogs; Fenbendazole; Giardiasis; Metronidazole; Pharmacopoeias as Topic; Quinacrine; United States; United States Food and Drug Administration | 1998 |
The effectiveness of benzimidazole derivatives for the treatment and prevention of histomonosis (blackhead) in turkeys.
Topics: Albendazole; Animals; Anthelmintics; Cecum; Female; Fenbendazole; Liver; Metronidazole; Poultry Diseases; Protozoan Infections; Trichomonadida; Turkeys; Weight Gain | 1999 |
Fixed drug eruption with albendazole and it's cross-sensitivity with metronidazole--a case report.
Topics: Adult; Albendazole; Antiprotozoal Agents; Cross Reactions; Drug Eruptions; Female; Humans; Metronidazole | 1998 |
Efficacy of various chemotherapeutic agents on the growth of Spironucleus vortens, an intestinal parasite of the freshwater angelfish.
Topics: Albendazole; Animals; Antiprotozoal Agents; Cell Count; Dimetridazole; Diplomonadida; Fenbendazole; Fish Diseases; Fishes; Intestinal Diseases, Parasitic; Magnesium Sulfate; Mebendazole; Metronidazole; Protozoan Infections; Protozoan Infections, Animal; Pyrimethamine | 1999 |
Confirmation of transmission of the microsporidian parasite Enterocytozoon bieneusi in South Africa.
Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Anti-Bacterial Agents; Antinematodal Agents; Clostridioides difficile; Cryptosporidium parvum; Diarrhea; Feces; Female; Humans; Mebendazole; Metronidazole; Microsporida; Microsporidiosis; South Africa; Spores | 2000 |
Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France.
Topics: Albendazole; Animals; Animals, Newborn; Anti-Infective Agents; Antiprotozoal Agents; Feces; Gerbillinae; Giardia lamblia; Giardiasis; Humans; Metronidazole; Mice | 2000 |
Drug susceptibility testing of anaerobic protozoa.
Topics: Albendazole; Animals; Anti-Infective Agents; Antiprotozoal Agents; Entamoeba; Giardia; Metronidazole; Microbial Sensitivity Tests; Trichomonas vaginalis | 2001 |
Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome.
Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Antiprotozoal Agents; Drug Resistance, Microbial; Giardia lamblia; Giardiasis; Humans; Male; Metronidazole; Nitro Compounds; Thiazoles; Treatment Outcome | 2001 |
Isolation, excystation and axenization of Giardia lamblia isolates: in vitro susceptibility to metronidazole and albendazole.
Topics: Albendazole; Animals; Antiprotozoal Agents; Cell Adhesion; Feces; Giardia lamblia; Giardiasis; Metronidazole; Portugal | 2003 |
Comparison between two common methods for measuring Giardia lamblia susceptibility to antiparasitic drugs in vitro.
Topics: Albendazole; Animals; Antiparasitic Agents; Giardia lamblia; Logistic Models; Metronidazole; Parasitic Sensitivity Tests | 2003 |
Synthesis and antiparasitic activity of albendazole and mebendazole analogues.
Topics: Albendazole; Animals; Antiparasitic Agents; Caenorhabditis elegans; Giardia lamblia; Mebendazole; Metronidazole | 2003 |
Flowcytometric assessment of the effect of drugs on Giardia lamblia trophozoites in vitro.
Topics: Albendazole; Animals; Antineoplastic Agents, Phytogenic; Antiprotozoal Agents; Cell Adhesion; Cell Cycle; Cell Survival; Cytoplasm; Dose-Response Relationship, Drug; Flow Cytometry; Giardia lamblia; Inhibitory Concentration 50; Metronidazole; Oxygen; Time Factors; Vincristine | 2004 |
Synthesis and antiprotozoal activity of some 2-(trifluoromethyl)-1H-benzimidazole bioisosteres.
Topics: Albendazole; Animals; Antimalarials; Antiprotozoal Agents; Benzimidazoles; Giardia lamblia; Giardiasis; Inhibitory Concentration 50; Malaria, Falciparum; Metronidazole; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Structure-Activity Relationship; Trichomonas Infections; Trichomonas vaginalis | 2006 |
HIV and parasitic infection and the effect of treatment among adult outpatients in Malawi.
Topics: Adult; Albendazole; Ambulatory Care; Anthelmintics; Antiprotozoal Agents; CD4 Lymphocyte Count; Feces; Female; Helminthiasis; HIV Infections; HIV-1; Humans; Intestinal Diseases, Parasitic; Malawi; Male; Medically Underserved Area; Metronidazole; Praziquantel; RNA, Viral; Viral Load; Virus Shedding | 2007 |
Therapy-resistant diarrhea due to Giardia lamblia in a patient with common variable immunodeficiency disease.
Topics: Albendazole; Animals; Antiprotozoal Agents; Common Variable Immunodeficiency; Diagnosis, Differential; Diarrhea; Feces; Giardia lamblia; Giardiasis; Humans; Lymphoma; Male; Metronidazole; Middle Aged | 2007 |
Treatment-ladder and genetic characterisation of parasites in refractory giardiasis after an outbreak in Norway.
Topics: Adolescent; Adult; Albendazole; Algorithms; Animals; Antimalarials; Antiprotozoal Agents; Disease Outbreaks; Drug Therapy, Combination; Feces; Female; Giardia; Giardiasis; Humans; Male; Metronidazole; Middle Aged; Norway; Paromomycin; Polymerase Chain Reaction; Quinacrine; Treatment Outcome | 2008 |
Effect of three drugs against Encephalitozoon cuniculi infection in immunosuppressed mice.
Topics: Albendazole; Animals; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cyclophosphamide; Cyclosporine; Encephalitozoon cuniculi; Encephalitozoonosis; Immunocompromised Host; Intestines; Kidney; Liver; Lung; Male; Metronidazole; Mice; Mice, Inbred BALB C; Spleen | 2013 |
Giardial triosephosphate isomerase as possible target of the cytotoxic effect of omeprazole in Giardia lamblia.
Topics: Albendazole; Antiprotozoal Agents; Axenic Culture; Cysteine; Dose-Response Relationship, Drug; Drug Resistance; Enzyme Inhibitors; Escherichia coli; Gene Expression; Giardia lamblia; Humans; Metronidazole; Mutation; Nitro Compounds; Omeprazole; Parasitic Sensitivity Tests; Protozoan Proteins; Recombinant Proteins; Spectrometry, Fluorescence; Thiazoles; Triose-Phosphate Isomerase; Trophozoites | 2014 |
Drug susceptibility testing in microaerophilic parasites: Cysteine strongly affects the effectivities of metronidazole and auranofin, a novel and promising antimicrobial.
Topics: Albendazole; Animals; Anti-Infective Agents; Antiparasitic Agents; Antiprotozoal Agents; Antirheumatic Agents; Auranofin; Culture Media; Cysteine; Entamoeba histolytica; Furazolidone; Giardia lamblia; Metronidazole; Nitro Compounds; Parasites; Parasitic Sensitivity Tests; Thiazoles; Trichomonas vaginalis | 2017 |
Treatment of refractory paediatric giardiasis using secnidazole plus albendazole: a case series.
Topics: Adolescent; Albendazole; Antiprotozoal Agents; Child; Child, Preschool; Drug Combinations; Female; Giardia lamblia; Giardiasis; Humans; Male; Metronidazole; Retrospective Studies | 2018 |
Giardiasis: report of a case refractory to treatment.
Topics: Adult; Albendazole; Antiprotozoal Agents; Furazolidone; Giardia lamblia; Giardiasis; Humans; Male; Metronidazole; Nitro Compounds; Nitroimidazoles; Thiazoles; Tinidazole; Treatment Failure | 2019 |
HPLC Determination of Imidazoles with Variant Anti-Infective Activity in Their Dosage Forms and Human Plasma.
Topics: Albendazole; Anti-Infective Agents; Calibration; Chemistry Techniques, Analytical; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Dosage Forms; Fenbendazole; Humans; Hydrogen-Ion Concentration; Imidazoles; Metronidazole; Omeprazole; Patient Safety; Reproducibility of Results; Solvents; Temperature; Ultraviolet Rays; United States; United States Food and Drug Administration | 2020 |
Elimination of Giardia duodenalis BIV in vivo using natural extracts in microbiome and dietary supplements.
Topics: Albendazole; Animals; Antiparasitic Agents; Citrus; Dietary Supplements; Giardia lamblia; Giardiasis; Male; Metronidazole; Mice; Microbiota; Plant Extracts; Random Allocation; Tea | 2022 |
Giardia duodenalis: Flavohemoglobin is involved in drug biotransformation and resistance to albendazole.
Topics: Albendazole; Animals; Anthelmintics; Biotransformation; Chromatography, Liquid; Cytochromes; Flavins; Giardia lamblia; Heme; Humans; Iron; Metronidazole; Mixed Function Oxygenases; Molecular Docking Simulation; RNA, Messenger; Sulfones; Sulfoxides; Superoxides; Tandem Mass Spectrometry; Trophozoites; Xanthine Oxidase; Xanthines | 2022 |